Liu Yu-Chuan, Chi Fan-Hsiang, Yang Ting-Hua, Liu Tien-Chen
Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan, China.
Department of Otolaryngology, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan, China.
World J Otorhinolaryngol Head Neck Surg. 2016 Feb 3;2(1):13-16. doi: 10.1016/j.wjorl.2015.11.001. eCollection 2016 Mar.
The purpose of the study is to report and to analyze the complications following intratympanic injections (ITI) of steroids. The occurrence rate of complications at different ITI sites, four quadrants of eardrum, was also compared.
A retrospective clinical review in a medical center. Each patient received ITI twice in a week for 2-3 consecutive weeks as a salvage therapy for sudden sensorineural hearing loss. Post-injection complications, especially transient dizziness and vertigo, were recorded. Patients with acute or chronic vertigo episodes in 1 month were excluded.
A total of 59 patients with sudden sensorineural hearing loss and a total of 278 times of ITI were performed in 1 year. The post-injection complications included pain, tongue numbness, transient dizziness, vertigo, tinnitus, and a small persistent perforation. There was no significant difference in the occurrence of these complications between the injections sites on the 4 quadrants of the tympanic membrane. However, there was statistical significance in the post-injection vertiginous episode after IT injections to posterior-inferior quadrant (Q3) and posterior-superior quadrant (Q4) compared to anterior-superior quadrant (Q1) and anterior-inferior quadrant (Q2) ( = 0.0113).
IT injection is recommended to be applied to the Q2 since the Q1 and Q4 injections are more likely to induce the adverse effect of tongue numbness, while the Q3 and Q4 areas are more likely to induce post-injection vertigo.
本研究旨在报告并分析鼓室内注射(ITI)类固醇后的并发症。同时比较在鼓膜四个象限不同ITI注射部位并发症的发生率。
在一家医疗中心进行回顾性临床研究。每位患者每周接受两次ITI,连续进行2至3周,作为突发性感音神经性听力损失的挽救治疗。记录注射后的并发症,尤其是短暂性头晕和眩晕。排除在1个月内有急性或慢性眩晕发作的患者。
1年内共对59例突发性感音神经性听力损失患者进行了278次ITI。注射后的并发症包括疼痛、舌麻木、短暂性头晕、眩晕、耳鸣和小的持续性穿孔。鼓膜四个象限注射部位之间这些并发症的发生率无显著差异。然而,与鼓膜前上象限(Q1)和前下象限(Q2)相比,向鼓膜后下象限(Q3)和后上象限(Q4)注射IT后,注射后眩晕发作有统计学意义(P = 0.0113)。
建议将IT注射应用于Q2,因为Q1和Q4注射更易引发舌麻木的不良反应,而Q3和Q4区域更易引发注射后眩晕。